Canaccord Calls Doximity, Inc. (DOCS)’s Post-Earnings Selloff an Overreaction And Sees Long-Term Upside

Canaccord believes Doximity, Inc.'s (DOCS) post-earnings selloff was an overreaction and sees long-term upside for the company.